|
CN101663327B
(zh)
*
|
2007-03-23 |
2014-05-07 |
惠氏公司 |
产生肺炎链球菌(streptococcus pneumoniae)荚膜多糖的缩短的纯化方法
|
|
GB0818453D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
|
CA2777837C
(en)
*
|
2008-10-27 |
2017-07-11 |
Novartis Ag |
Purification method
|
|
BRPI0922981A8
(pt)
*
|
2008-12-18 |
2019-11-26 |
Wyeth Llc |
método para o controle do peso molecular polissacarídeo para o sorotipo 19a de streptococcus pneumoniae
|
|
ES2749952T3
(es)
*
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
|
US20120052088A1
(en)
|
2009-04-30 |
2012-03-01 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
SA110310528B1
(ar)
|
2009-06-22 |
2014-07-02 |
Wyeth Llc |
التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
|
|
SG10201406432RA
(en)
|
2009-06-22 |
2014-11-27 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
TW201136603A
(en)
*
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
|
WO2011145108A2
(en)
*
|
2010-05-15 |
2011-11-24 |
Serum Institute Of India Ltd. |
Purification of capsular polysaccharides
|
|
BR112013024322B1
(pt)
*
|
2011-03-22 |
2020-04-22 |
Serum Inst India Ltd |
processo para preparação de polissacarídeos
|
|
CN102660601B
(zh)
*
|
2012-04-17 |
2015-10-28 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
CN102660603B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
一种快速纯化细菌荚膜多糖的方法
|
|
CN102660602B
(zh)
*
|
2012-04-17 |
2015-03-25 |
江苏康泰生物医学技术有限公司 |
快速纯化细菌荚膜多糖的方法
|
|
US9650411B2
(en)
*
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
|
RU2606022C2
(ru)
*
|
2012-09-07 |
2017-01-10 |
Ск Кемикалс Ко., Лтд. |
Способ получения капсульного полисахарида с пневмококковым серотипом
|
|
RU2015106791A
(ru)
|
2012-10-03 |
2016-11-20 |
Глэксосмитиклайн Байолоджикалз Са |
Иммуногенные композиции
|
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
|
US9910041B2
(en)
|
2013-07-12 |
2018-03-06 |
Emd Millipore Corporation |
Method of determining virus removal from a sample containing a target protein using activated carbon
|
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN110859957B
(zh)
|
2014-01-21 |
2024-04-12 |
辉瑞公司 |
包含缀合荚膜糖抗原的免疫原性组合物及其用途
|
|
BR112016015835B1
(pt)
|
2014-01-21 |
2023-12-26 |
Pfizer Inc |
Processo de preparação de conjugados compreendendo polissacarídeos capsulares de streptococcus pneumoniae
|
|
PL3096786T3
(pl)
|
2014-01-21 |
2021-11-08 |
Pfizer Inc. |
Polisacharydy otoczkowe streptococcus pneumoniae i ich koniugaty
|
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
HUE062499T2
(hu)
|
2015-01-15 |
2023-11-28 |
Pfizer |
Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények
|
|
MY182282A
(en)
|
2015-05-04 |
2021-01-18 |
Pfizer |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
WO2016204265A1
(ja)
*
|
2015-06-18 |
2016-12-22 |
一般財団法人阪大微生物病研究会 |
肺炎球菌補体依存性殺菌能測定方法
|
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
CN105131139B
(zh)
*
|
2015-07-31 |
2018-02-13 |
兰州生物制品研究所有限责任公司 |
一种肺炎链球菌荚膜多糖的纯化方法
|
|
JP6884145B2
(ja)
|
2015-11-20 |
2021-06-09 |
ファイザー・インク |
肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
|
|
CA3031799A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
CN110366428B
(zh)
|
2016-12-30 |
2024-05-17 |
Vaxcyte公司 |
具有非天然氨基酸的多肽-抗原缀合物
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
EP4656208A3
(en)
|
2017-01-31 |
2026-03-04 |
Merck Sharp & Dohme LLC |
Methods for making polysaccharide-protein conjugates
|
|
CN110225757A
(zh)
|
2017-01-31 |
2019-09-10 |
默沙东公司 |
由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
|
|
MX2019009869A
(es)
|
2017-02-24 |
2019-10-02 |
Merck Sharp & Dohme |
Formulaciones de vacunas de conjugado de neumococos.
|
|
JP7680185B2
(ja)
|
2017-02-24 |
2025-05-20 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎連鎖球菌多糖－タンパク質コンジュゲートの免疫原性の増強
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
WO2018227177A1
(en)
|
2017-06-10 |
2018-12-13 |
Inventprise, Llc |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
|
US10702596B2
(en)
|
2017-07-05 |
2020-07-07 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
JP7111799B2
(ja)
*
|
2017-07-05 |
2022-08-02 |
インベントプライズ リミテッド ライアビリティ カンパニー |
溶菌酵素、接線流濾過、及びマルチモードクロマトグラフィを用いたワクチン生産のための多糖精製
|
|
MX394768B
(es)
|
2017-09-07 |
2025-03-21 |
Merck Sharp & Dohme Llc |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina.
|
|
CN111093650B
(zh)
|
2017-09-07 |
2024-03-01 |
默沙东有限责任公司 |
肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
|
|
MX394767B
(es)
|
2017-09-07 |
2025-03-24 |
Merck Sharp & Dohme Llc |
Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
|
|
CN107936128B
(zh)
*
|
2017-11-22 |
2020-07-03 |
成都欧林生物科技股份有限公司 |
一种简便有效的细菌疫苗纯化方法
|
|
ES3058336T3
(es)
|
2017-12-06 |
2026-03-10 |
Merck Sharp & Dohme Llc |
Composiciones que comprenden conjugados polisacárido-proteína de Streptococcus pneumoniae y métodos de uso de los mismos
|
|
BR112020014978A2
(pt)
|
2018-02-05 |
2020-12-22 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
EP3749357A4
(en)
|
2018-02-05 |
2022-04-20 |
Sanofi Pasteur, Inc. |
POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
|
|
EP3788143B1
(en)
|
2018-04-30 |
2023-06-28 |
Merck Sharp & Dohme LLC |
Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
|
|
US12144855B2
(en)
|
2018-04-30 |
2024-11-19 |
Merck Sharp & Dohme Llc |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
|
|
EP3787673A4
(en)
|
2018-04-30 |
2022-04-27 |
Merck Sharp & Dohme Corp. |
Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
|
|
DK3817775T3
(da)
|
2018-07-04 |
2024-09-16 |
Vaxcyte Inc |
Forbedringer i immunogene konjugater
|
|
WO2020010000A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Improved methods for the preparation of immunogenic conjugates
|
|
WO2020010016A1
(en)
|
2018-07-04 |
2020-01-09 |
Sutrovax, Inc. |
Self-adjuvanted immunogenic conjugates
|
|
EP3824019A1
(en)
*
|
2018-07-19 |
2021-05-26 |
GlaxoSmithKline Biologicals SA |
Processes for preparing dried polysaccharides
|
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
|
CR20210333A
(es)
|
2018-12-19 |
2021-08-18 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
|
|
JP7239509B6
(ja)
*
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
|
WO2020208502A1
(en)
|
2019-04-10 |
2020-10-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
US12473379B2
(en)
*
|
2019-09-06 |
2025-11-18 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
|
CN119371566A
(zh)
|
2020-02-21 |
2025-01-28 |
辉瑞公司 |
糖类的纯化
|
|
JP2023528657A
(ja)
*
|
2020-06-12 |
2023-07-05 |
ビーエーエスエフ ソシエタス・ヨーロピア |
発酵ブロスの改善された脱塩及び例えばオリゴ糖のファインケミカルの精製
|
|
WO2022035816A1
(en)
|
2020-08-10 |
2022-02-17 |
Inventprise, Llc |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
KR20230056727A
(ko)
|
2020-08-26 |
2023-04-27 |
화이자 인코포레이티드 |
B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
|
|
GB202016165D0
(en)
|
2020-10-12 |
2020-11-25 |
Optivalent Ltd |
Vaccine
|
|
WO2022084852A1
(en)
|
2020-10-22 |
2022-04-28 |
Pfizer Inc. |
Methods for purifying bacterial polysaccharides
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
JP7804673B2
(ja)
|
2020-11-10 |
2026-01-22 |
ファイザー・インク |
コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
|
JP2024517780A
(ja)
|
2021-05-03 |
2024-04-23 |
ファイザー・インク |
細菌およびベータコロナウイルス感染症に対するワクチン接種
|
|
WO2022234416A1
(en)
|
2021-05-03 |
2022-11-10 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
JP2024521847A
(ja)
|
2021-05-28 |
2024-06-04 |
ファイザー・インク |
コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
MX2023013434A
(es)
|
2021-05-28 |
2023-12-12 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos.
|
|
CA3247998A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions based on conjugated capsular saccharidic antigens and their uses
|
|
GB2614916A
(en)
|
2022-01-25 |
2023-07-26 |
Optivalent Ltd |
Intradermal vaccine complement
|
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
|
WO2024084397A1
(en)
|
2022-10-19 |
2024-04-25 |
Pfizer Inc. |
Vaccination against pneumoccocal and covid-19 infections
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
EP4622665A2
(en)
|
2022-11-22 |
2025-10-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
AU2023403045A1
(en)
|
2022-12-01 |
2025-06-12 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
PE20252774A1
(es)
|
2023-03-30 |
2025-12-22 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
|
|
AU2024255922A1
(en)
|
2023-04-14 |
2025-10-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
CN121532194A
(zh)
|
2023-05-18 |
2026-02-13 |
默沙东有限责任公司 |
用于肺炎球菌疫苗的化合物及佐剂制剂
|
|
KR20260015203A
(ko)
|
2023-05-19 |
2026-02-02 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
호흡기 세포융합 바이러스 및 스트렙토코쿠스 뉴모니아에 감염에 대한 면역 반응을 유발하는 방법
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025219908A2
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Media and fermentation methods for polysaccharide production in bacterial cell culture
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|
